HemaSphere (Aug 2023)

P1492: A NEW POTENTIAL AND PREVALENT SIDE EFFECT OF FERRIC CARBOXYMALTOSE: METHEMOGLOBINEMIA. A CASE-CONTROL STUDY.

  • Muhammet Özbilen,
  • Şeyda Tuba Savrun,
  • Ali Aygün,
  • Yasemin Kaya

DOI
https://doi.org/10.1097/01.HS9.0000972848.82517.3f
Journal volume & issue
Vol. 7
p. e825173f

Abstract

Read online

No abstracts available.